O	0	6	Effect
O	7	9	of
B-intervention	10	13	Low
I-intervention	13	14	-
I-intervention	14	23	Intensity
I-intervention	24	32	Physical
I-intervention	33	41	Activity
I-intervention	42	45	and
I-intervention	46	54	Moderate
I-intervention	54	55	-
I-intervention	56	58	to
I-intervention	59	63	High
I-intervention	63	64	-
I-intervention	64	73	Intensity
I-intervention	74	82	Physical
I-intervention	83	91	Exercise
O	92	98	During
O	99	107	Adjuvant
O	108	120	Chemotherapy
O	121	123	on
O	124	132	Physical
O	133	140	Fitness
O	140	141	,
O	142	149	Fatigue
O	149	150	,
O	151	154	and
O	155	167	Chemotherapy
O	168	178	Completion
O	179	184	Rates
O	184	185	:
O	186	193	Results
O	194	196	of
O	197	200	the
O	201	206	PACES
O	207	217	Randomized
O	218	226	Clinical
O	227	232	Trial
O	232	233	.

O	234	236	We
O	237	246	evaluated
O	247	250	the
O	251	264	effectiveness
O	265	267	of
O	268	269	a
O	270	273	low
O	273	274	-
O	274	283	intensity
O	283	284	,
O	285	289	home
O	289	290	-
O	290	295	based
O	296	304	physical
O	305	313	activity
O	314	321	program
O	322	323	(
O	323	327	Onco
O	327	328	-
O	328	332	Move
O	332	333	)
O	334	337	and
O	338	339	a
O	340	348	moderate
O	348	349	-
O	350	352	to
O	353	357	high
O	357	358	-
O	358	367	intensity
O	367	368	,
O	369	377	combined
O	378	388	supervised
O	389	399	resistance
O	400	403	and
O	404	411	aerobic
O	412	420	exercise
O	421	428	program
O	429	430	(
O	430	437	OnTrack
O	437	438	)
O	439	445	versus
B-control	446	451	usual
I-control	452	456	care
I-control	457	458	(
I-control	458	460	UC
I-control	460	461	)
O	462	464	in
O	465	476	maintaining
O	477	479	or
O	480	489	enhancing
O	490	498	physical
O	499	506	fitness
O	506	507	,
O	508	518	minimizing
O	519	526	fatigue
O	526	527	,
O	528	537	enhancing
O	538	544	health
O	544	545	-
O	545	552	related
O	553	560	quality
O	561	563	of
O	564	568	life
O	568	569	,
O	570	573	and
O	574	584	optimizing
O	585	597	chemotherapy
O	598	608	completion
O	609	614	rates
O	615	617	in
B-eligibility	618	626	patients
I-eligibility	627	637	undergoing
I-eligibility	638	646	adjuvant
I-eligibility	647	659	chemotherapy
I-eligibility	660	663	for
I-eligibility	664	670	breast
I-eligibility	671	677	cancer
O	677	678	.

O	679	681	We
O	682	690	randomly
O	691	699	assigned
O	700	708	patients
O	709	712	who
O	713	717	were
O	718	727	scheduled
O	728	730	to
O	731	738	undergo
O	739	747	adjuvant
O	748	760	chemotherapy
O	761	762	(
O	762	763	N
O	764	765	=
B-total-participants	766	769	230
O	769	770	)
O	771	773	to
O	774	778	Onco
O	778	779	-
O	779	783	Move
O	783	784	,
O	785	792	OnTrack
O	792	793	,
O	794	796	or
O	797	799	UC
O	799	800	.

O	801	812	Performance
O	812	813	-
O	813	818	based
O	819	822	and
O	823	827	self
O	827	828	-
O	828	836	reported
O	837	845	outcomes
O	846	850	were
O	851	859	assessed
O	860	866	before
O	867	873	random
O	874	884	assignment
O	884	885	,
O	886	888	at
O	889	892	the
O	893	896	end
O	897	899	of
O	900	912	chemotherapy
O	912	913	,
O	914	917	and
O	918	920	at
O	921	924	the
O	925	926	6
O	926	927	-
O	927	932	month
O	933	939	follow
O	939	940	-
O	940	942	up
O	942	943	.

O	944	946	We
O	947	951	used
O	952	963	generalized
O	964	974	estimating
O	975	984	equations
O	985	987	to
O	988	995	compare
O	996	999	the
O	1000	1006	groups
O	1007	1011	over
O	1012	1016	time
O	1016	1017	.

O	1018	1022	Onco
O	1022	1023	-
O	1023	1027	Move
O	1028	1031	and
O	1032	1039	OnTrack
O	1040	1048	resulted
O	1049	1051	in
O	1052	1056	less
O	1057	1064	decline
O	1065	1067	in
B-outcome	1068	1085	cardiorespiratory
I-outcome	1086	1093	fitness
O	1094	1095	(
O	1095	1096	P
O	1097	1098	<
O	1099	1100	.
O	1100	1103	001
O	1103	1104	)
O	1104	1105	,
O	1106	1112	better
B-outcome	1113	1121	physical
I-outcome	1122	1133	functioning
O	1134	1135	(
O	1135	1136	P
O	1137	1138	â‰¤
O	1139	1140	.
O	1140	1143	001
O	1143	1144	)
O	1144	1145	,
O	1146	1150	less
B-outcome	1151	1157	nausea
I-outcome	1158	1161	and
I-outcome	1162	1170	vomiting
O	1171	1172	(
O	1172	1173	P
O	1174	1175	=
O	1176	1177	.
O	1177	1180	029
O	1181	1184	and
O	1185	1186	.
O	1186	1189	031
O	1189	1190	,
O	1191	1203	respectively
O	1203	1204	)
O	1205	1208	and
O	1209	1213	less
B-outcome	1214	1218	pain
O	1219	1220	(
O	1220	1221	P
O	1222	1223	=
O	1224	1225	.
O	1225	1228	003
O	1229	1232	and
O	1233	1234	.
O	1234	1237	011
O	1237	1238	,
O	1239	1251	respectively
O	1251	1252	)
O	1253	1261	compared
O	1262	1266	with
O	1267	1269	UC
O	1269	1270	.

O	1271	1278	OnTrack
O	1279	1283	also
O	1284	1292	resulted
O	1293	1295	in
O	1296	1302	better
O	1303	1311	outcomes
O	1312	1315	for
B-outcome	1316	1322	muscle
I-outcome	1323	1331	strength
O	1332	1333	(
O	1333	1334	P
O	1335	1336	=
O	1337	1338	.
O	1338	1341	002
O	1341	1342	)
O	1343	1346	and
B-outcome	1347	1355	physical
I-outcome	1356	1363	fatigue
O	1364	1365	(
O	1365	1366	P
O	1367	1368	<
O	1369	1370	.
O	1370	1373	001
O	1373	1374	)
O	1374	1375	.

O	1376	1378	At
O	1379	1382	the
O	1383	1384	6
O	1384	1385	-
O	1385	1390	month
O	1391	1397	follow
O	1397	1398	-
O	1398	1400	up
O	1400	1401	,
O	1402	1406	most
O	1407	1415	outcomes
O	1416	1424	returned
O	1425	1427	to
O	1428	1436	baseline
O	1437	1443	levels
O	1444	1447	for
O	1448	1451	all
O	1452	1457	three
O	1458	1464	groups
O	1464	1465	.

O	1466	1467	A
O	1468	1475	smaller
O	1476	1486	percentage
O	1487	1489	of
O	1490	1502	participants
O	1503	1505	in
O	1506	1513	OnTrack
O	1514	1522	required
B-outcome	1523	1535	chemotherapy
I-outcome	1536	1540	dose
I-outcome	1541	1552	adjustments
O	1553	1557	than
O	1558	1563	those
O	1564	1566	in
O	1567	1570	the
O	1571	1573	UC
O	1574	1576	or
O	1577	1581	Onco
O	1581	1582	-
O	1582	1586	Move
O	1587	1593	groups
O	1594	1595	(
O	1595	1596	P
O	1597	1598	=
O	1599	1600	.
O	1600	1603	002
O	1603	1604	)
O	1604	1605	.

O	1606	1610	Both
O	1611	1623	intervention
O	1624	1630	groups
O	1631	1639	returned
O	1640	1647	earlier
O	1648	1649	(
O	1649	1650	P
O	1651	1652	=
O	1653	1654	.
O	1654	1657	012
O	1657	1658	)
O	1658	1659	,
O	1660	1662	as
O	1663	1667	well
O	1668	1670	as
O	1671	1674	for
O	1675	1679	more
O	1680	1685	hours
O	1686	1689	per
O	1690	1694	week
O	1695	1696	(
O	1696	1697	P
O	1698	1699	=
O	1700	1701	.
O	1701	1704	014
O	1704	1705	)
O	1705	1706	,
O	1707	1709	to
O	1710	1714	work
O	1715	1719	than
O	1720	1723	the
O	1724	1731	control
O	1732	1737	group
O	1737	1738	.

O	1739	1740	A
O	1741	1751	supervised
O	1751	1752	,
O	1753	1761	moderate
O	1761	1762	-
O	1763	1765	to
O	1766	1770	high
O	1770	1771	-
O	1771	1780	intensity
O	1780	1781	,
O	1782	1790	combined
O	1791	1801	resistance
O	1802	1805	and
O	1806	1813	aerobic
O	1814	1822	exercise
O	1823	1830	program
O	1831	1833	is
O	1834	1838	most
O	1839	1848	effective
O	1849	1852	for
O	1853	1861	patients
O	1862	1866	with
O	1867	1873	breast
O	1874	1880	cancer
O	1881	1891	undergoing
O	1892	1900	adjuvant
O	1901	1913	chemotherapy
O	1913	1914	.

O	1915	1916	A
O	1917	1921	home
O	1921	1922	-
O	1922	1927	based
O	1927	1928	,
O	1929	1932	low
O	1932	1933	-
O	1933	1942	intensity
O	1943	1951	physical
O	1952	1960	activity
O	1961	1968	program
O	1969	1979	represents
O	1980	1981	a
O	1982	1988	viable
O	1989	2000	alternative
O	2001	2004	for
O	2005	2010	women
O	2011	2014	who
O	2015	2018	are
O	2019	2025	unable
O	2026	2028	or
O	2029	2038	unwilling
O	2039	2041	to
O	2042	2048	follow
O	2049	2052	the
O	2053	2059	higher
O	2060	2069	intensity
O	2070	2077	program
O	2077	2078	.
